Study:
A Groupwide Biology and Banking Study for Ewing Sarcoma
Rationale:
Genetic testing may help predict how cancer will respond to treatment and allow
doctors to plan more effective therapy.
Purpose:
Diagnostic trial to study genetic differences in patients who have Ewing`s sarcoma.
Study Status: Completed
Recruiting:
n/a
| Condition |
Intervention |
Phase |
|
Sarcoma |
Other: laboratory biomarker analysis |
N/A |
Verified by
Children`s Oncology Group
April, 2013
Sponsored by: Children`s Oncology Group
Information provided by: Children`s Oncology Group
ClinicalTrials.gov identifier: NCT00048984
Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio 44195
United States
Daniel C. West, MD., Study Chair